Portal de Periódicos da CAPES

Pharmacology and Therapeutic Effects of Mepirodipine

1991; Wiley; Volume: 9; Issue: 4 Linguagem: Inglês

10.1111/j.1527-3466.1991.tb00420.x

1527-3466

Hiroyasu Satoh,

Pain Mechanisms and Treatments

Cardiovascular Drug ReviewsVolume 9, Issue 4 p. 340-356 Free to Read Pharmacology and Therapeutic Effects of Mepirodipine Hiroyasu Satoh, Hiroyasu Satoh Department of Pharmacology, Nara Medical University, Kashihara Nara, 634, JapanSearch for more papers by this author Hiroyasu Satoh, Hiroyasu Satoh Department of Pharmacology, Nara Medical University, Kashihara Nara, 634, JapanSearch for more papers by this author First published: December 1991 https://doi.org/10.1111/j.1527-3466.1991.tb00420.xCitations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Aimer W, Palade PT. Slow calcium and potassium currents across frog muscle membrane: measurements with a vaseline-gap technique. J Physiol (Lond) 1981; 312: 159– 76. 2 Bean BP. Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. Proc Natl Acad Sci USA 1984; 81: 6388– 92. 3 Bean BP, Sturek M, Puga A, Hermsmeyer K. Calcium channels in muscle cell isolated from rat mesenteric arteries: modulation by dihydropyridine drugs. Circ Res 1986; 59: 229– 35. 4 Bolger GT, Gengo P, Klockowski R, et al. Characterization of binding of the Ca2+ channel antagonist, nitrendipine, to guinea pig ileal muscle. J Pharmacol Exp Ther 1983; 225: 291– 309. 5 Catterall AW. Structure and function of voltage-sensitive ion channels. Science 1988; 242: 50– 61. 6 Fabiato A, Fabiato F. Calcium and cardiac excitation-contraction coupling. Annu Rev Physiol 1979; 41: 473– 84. 7 Fozzard HA. Heart: excitation-contraction coupling. Annu Rev Physiol 1977; 39: 201– 20. 8 Fleckenstein A. Calcium antagonism in heart and smooth muscle. New York : John Wiley & Sons, 1983: 1– 38. 9 Glossmann H, Ferry DR, Goll A, Rombusch M. Molecular pharmacology of the calcium channels: evidence for subtypes, multiple drug receptor sites, channel subunits and the development of a radioiodinated 1,4-dihydropyridines calcium channel label, [125I]-iodipine. J Cardiovasc Pharmacol 1984;( 6:Suppl 4): S608– 21. 10 Godfraind T. Calcium entry blockade and excitation concentration coupling in the cardiovascular system (with an attempt of pharmacology classification). Acta Pharmacol Toxicol 1986; 58: 5– 30. 11 Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev 1986; 38: 321– 416. 12 Gotoh Y, Imaizumi Y, Watanabe M, Shibata EF, Clark RB, Giles WR. Inhibition of transient outward K+ current by DHP Ca2+ antagonists and agonists in rabbit cardiac myocytes. Am J Physiol 1991; 260: H1737– 42. 13 Hess P, Lansman JB, Tsien RW. Calcium channel selectivity for divalent and monovalent cations. J Gen Physiol 1986; 88: 293– 319. 14 Inagaki O, Momose N, Nakagawa C, Honda K. Effects of YM-09730-5, a new calcium antaginist, on blood pressure and vasocontractor response in spontaneously-hypertensive rats. Jpn J Pharmacol 1987; 43: 292. 15 Inagaki O, Shibasaki M, Honda K, et al. Cardio-vascular effect of YM-09730-5, an optically pure dihydropyridine calcium antagonist. Jpn J Pharmacol 1986;Suppl. 40: 232. 16 Kashiwabara T, Nakayama K, Yamada S, Tanaka Y. Long-lasting and potent Ca antagonistic actions of a novel dihydropyridine with two asymmetric centers (YM-09730-5) assessed in the porcine coronary artery. Jpn J Pharmacol 1987;Suppl. 43: 731. 17 Kass RS, Kraft DS. Negative surface charge density near heart calcium channels. Relevance to block by dihydropyridines. J Gen Physiol 1987; 89: 629– 44. 18 Kawashima K, Toda H, Oohata H, et al. Antihypertensive and diuretic effects of YM-093730-5, a new calcium antagonist, in stroke-prone spontaneously hypertensive rats. Gen Pharmacol 1991; 22: 263– 6. 19 Lefevre IA, Coulombe A, Coraboeuf E. The calcium antagonist D-600 inhibits calcium-independent transient outward current in isolated rat ventricular myocytes. J Physiol (Lond) 1991; 432: 65– 80. 20 Mekata F, Hashimoto K. Effects of a new dihydropyridine calcium blocker, mepirodipine, on isolated monkey coronary artery. Asia Pacific J Pharmacol 1990; 5: 285– 90. 21 Molyvdas P-A, Sperelakis N. Effects of calcium antagonistic drugs on the electrical activity of rabbit sino-atrial node. Br J Pharmacol 1986; 88: 249– 58. 22 Motomura S, Hashimoto K. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)–(S) conformation, with those of nifedipine and nicardipine. Jpn J Pharmacol 1990; 52: 319– 30. 23 Nakayama K, Kashiwabara S, Yamada S, et al. Assessment in pig coronary artery of long-lasting and potent calcium antagonistic actions of the novel dihydropyridine derivative mepirodipine hydrochloride. Arzneimittelforschung 1989; 39: 50– 5. 24 Neyler WG. Calcium antagonists. London : Academic Press, 1988. 25 Nilius B, Hess P, Lansman JB, Tsien RW. A novel type of cardiac calcium channel in ventricular cells. Nature (Lond) 1985; 316: 443– 6. 26 Noble D. The surprising heart: a review of recent progress in cardiac electrophysiology. J Physiol (Lond) 1984; 353: 1– 50. 27 Nowycky MC, Fox AP, Tsien RW. Three types of neuronal calcium channel with different calcium agonist selectivity. Nature (Lond) 1985; 316: 440– 3. 28 Pang DC, Sperelakis N. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities. Biochem Pharmacol 1984; 33: 821– 6. 29 Reuter H. Properties of two inward membrane currents in the heart. Annu Rev Physiol 1979; 41: 413– 24. 30 Rhode DG, Sarmiento JG, Herbette LG. Kinetics of binding of membrane active drugs to receptor sites. Mol Pharmacol 1985; 27: 612– 23. 31 Roy F, Pruneau D. Comparison of the effects of nifedipine, diltiazem and verapamil on the mechanical activity of rabbit papillary muscles induced by barium chloride. Pharmacology 1986; 33: 69– 75. 32 Sanguinetti MC, Kass RS. Voltage-dependent block of calcium channel in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res 1984; 55: 336– 48. 33 Satoh H, Hasegawa J, Vassalle M. On the characteristics of the inward tail current induced by calcium overload. J Mol Cell Cardiol 1988; 21: 5– 20. 34 Satoh H, Hashimoto K. Comparative effects of a new calcium channel antagonist, mepirodipine, on rabbit spontaneously beating sino-atrial node cells. Eur J Pharmacol 1991; 193: 9– 13. 35 Satoh H, Tsuchida K, Hashimoto K. Electrophysiological actions of A23187 and X-537A in spontaneously beating and in voltage-clamped rabbit sino-atrial node preparations. Naunyn Schmidebergs Arch Pharmacol 1989; 339: 320– 6. 36 Satoh H, Vassalle M. Reversal of caffeine-induced calcium overload in cardiac Purkinje fibers. J Exp Pharmacol Ther 1987; 234: 172– 9. 37 Schneck DW, Rubin A, Knadler MP, Bowsher R, Apathy J. Efficacy and disposition of a new calcium antagonist. Clin Pharmacol Ther 1987; 41:Suppl 234. 38 Serruys PW, Vanhaleweyk GLJ, Hugenholtz PG. The hemodynamic effects of the calcium channel blocking agents. In: PH Stone, EM Antman, eds. Calcium channel blocking agents in the treatment of cardiovascular disorders. New York : Futura Publishing, 1983: 203– 40. 39 Takenaka T, Asano M, Shiono K, Shibata M, Inagaki O. Cardiovascular pharmacology of nicardipine in animals. Br J Clin Pharmacol 1985; 20:Suppl 1; 7S– 22S. 40 Tamazawa K, Arima H, Kojima T, et al. Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl-methyl-2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3, 5-dicarboxylate. J Med Chem 1986; 29: 2504– 11. 41 Teramura T, Kobayashi S, Higuchi S. Determination of mepirodipine in plasma by capillary column gas chromatography-negative-ion chemical ionization mass spectrometry. J Chromatogr 1990; 528: 191– 8. 42 Teramura T, Kobayashi S, Higuchi S, et al. Pharmacokinetic study on mepirodipine hydrochloride: tissue distribution of 14C-mepirodipine hydrochloride and its transfer into fetus and milk rats. Clin Rep 1990; 24: 213– 28. 43 Teramura T, Tashiro K, Kobayashi S, et al. Pharmacokinetic study on mepirodipine hydrochloride: absorption and excretion of 14C-mepirodipine hydrochloride in rats and dogs. Clin Rep 1990; 24: 203– 11. 44 Towart R, Wehinger E, Meyer H. Effects of unsymmetrical ester substituted 1,4-dihydropyridine derivates and their optical isomers on contraction of smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 1981; 317: 183– 5. 45 Vaghy PI, Striessnig J, Miwa K, et al. Identification of a novel 1,4-dihydropyridine and phenylalkylamine-binding polypeptide in calcium channel preparations. J Biol Chem 1987; 262: 14337– 42. 46 Vaughan Williams EM. Antiarrhythmic action. London : Academic Press, 1980. 47 Yatsu T, Takizawa K, Inagaki O, Shibasaki M, Honda K. Renal effects of YM-09730-5, a new dihydropyridine calcium antagonist in anaesthetized dogs. Jpn J Pharmacol 1988;Suppl 46: 227. Citing Literature Volume9, Issue4December 1991Pages 340-356 ReferencesRelatedInformation